Yuhei Koike
Overview
Explore the profile of Yuhei Koike including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yui M, Nakamura S, Koike Y, Hirota K, Yoshida K, Yoshida A, et al.
Anticancer Res
. 2025 Mar;
45(3):1105-1115.
PMID: 40037871
Background/aim: The effect of modern molecular-targeted agents (MTAs), on vertebral metastases in non-small cell lung cancer (NSCLC) remains inadequately characterized. We investigated the local control effects of MTAs on vertebral...
2.
Anetai Y, Doi K, Takegawa H, Koike Y, Yui M, Yoshida A, et al.
Phys Med Biol
. 2024 Nov;
69(24.
PMID: 39577089
Diffusion equation (DE) imaging processing is promising to enhance images showing lesions of bone metastasis (LBM). The Perona-Malik diffusion (PMD) model, which has been widely used and studied, is an...
3.
Koike Y, Takegawa H, Anetai Y, Nakamura S, Yoshida K, Yoshida A, et al.
J Imaging Inform Med
. 2024 Nov;
PMID: 39511015
Cone-beam computed tomography (CBCT) is widely utilized in image-guided radiation therapy; however, its image quality is poor compared to planning CT (pCT), thus restricting its utility for adaptive radiotherapy (ART)....
4.
Yoshida K, Tanaka Y, Nakamura S, Yoshida A, Yui M, Hirota K, et al.
Oral Radiol
. 2024 Oct;
41(1):144-150.
PMID: 39432203
Only a few studies have explored whether high-dose-rate interstitial brachytherapy (HDR-ISBT) can be indicated as a palliative/symptomatic treatment. We present the good results of palliative treatment using HDR-ISBT combined with...
5.
Muramoto K, Urabe F, Koike Y, Yamamoto S, Suzuki H, Miyajima K, et al.
Urol Oncol
. 2024 May;
42(10):332.e21-332.e32.
PMID: 38729868
Background: The effect of radical nephroureterectomy (RNUx) on postoperative renal function in patients diagnosed with upper tract urothelial carcinoma (UTUC) has not been thoroughly explored. Methods: We conducted a retrospective...
6.
Koike Y, Ohira S, Kihara S, Anetai Y, Takegawa H, Nakamura S, et al.
J Imaging Inform Med
. 2024 Apr;
37(5):2688-2697.
PMID: 38637424
While dual-energy computed tomography (DECT) technology introduces energy-specific information in clinical practice, single-energy CT (SECT) is predominantly used, limiting the number of people who can benefit from DECT. This study...
7.
Hirasawa Y, Adachi T, Hashimoto T, Fukuokaya W, Koike Y, Yata Y, et al.
J Cancer Res Clin Oncol
. 2024 Apr;
150(4):182.
PMID: 38592548
Objectives: Enfortumab vedotin (EV) is a novel antibody-drug conjugate approved for metastatic urothelial carcinoma (UC) refractory to prior treatment with immune checkpoint inhibitors (ICIs). However, the difference in efficacy of...
8.
Yoshida K, Akita K, Yoshida A, Yui M, Hirota K, Takegawa H, et al.
J Palliat Med
. 2024 Apr;
27(8):1102-1106.
PMID: 38579134
Delivering cancer treatment to elderly patients with dementia is often challenging. We describe performing palliative surface mold brachytherapy (SMBT) in an elderly patient with advanced dementia for pain control using...
9.
Hashimoto M, Fukuokaya W, Yanagisawa T, Yamamoto S, Koike Y, Imai Y, et al.
Int J Clin Oncol
. 2024 Mar;
29(5):612-619.
PMID: 38430304
Background: This study aims to investigate the relationship between comorbidities and survival in patients with mUC treated with pembrolizumab as a second-line treatment. Methods: From February 2018 to October 2021,...
10.
Koike Y, Ohira S, Yamamoto Y, Miyazaki M, Konishi K, Nakamura S, et al.
Int J Comput Assist Radiol Surg
. 2024 Jan;
19(3):541-551.
PMID: 38219257
Purpose: While dual-energy computed tomography (DECT) images provide clinically useful information than single-energy CT (SECT), SECT remains the most widely used CT system globally, and only a few institutions can...